Kennewick, Tonga Clinical Trials

A listing of Kennewick, Tonga clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 53870 clinical trials
Featured trial
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis

The primary objectives of this study are to evaluate the safety and efficacy of filgotinib in the induction and maintenance treatment of moderately to severely active ulcerative colitis (UC) in participants who are biologic-naive and biologic-experienced. Participants who complete the study, or do not meet protocol response or remission criteria …

immunomodulators
tumor necrosis factor alpha
corticosteroids
vedolizumab
remission
  • 2136 views
  • 26 Apr, 2019
  • 1 location
Featured trial
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease

The primary objectives of this study are to evaluate the safety and efficacy of filgotinib during induction and maintenance treatment of moderately to severely active Crohn's disease (CD) in participants who are biologic-naive and biologic-experienced. Participants who complete the study, or do not meet protocol response or remission criteria at …

tumour necrosis
ustekinumab
tumor necrosis factor alpha
corticosteroids
tumor necrosis factor
  • 2243 views
  • 08 May, 2018
  • 1 location
Featured trial
Study of the Efficacy and Safety of Parsaclisib in Participants With Primary Warm Autoimmune Hemolytic Anemia (PATHWAY) (PATHWAY)

The purpose of this study is to evaluate the efficacy and safety of parsclisib compared with placebo in participants with Primary Warm Autoimmune Hemolytic Anemia (wAIHA),

  • 0 views
  • 16 May, 2022
  • 14 locations
Featured trial
Study of Oral Navitoclax Tablet in Combination With Oral Ruxolitinib Tablet to Assess Change in Spleen Volume in Adult Participants With Relapsed/Refractory Myelofibrosis

www.MyelofibrosisResearch.com Myelofibrosis (MF) is a bone marrow illness that affects blood-forming tissues in the body. MF disturbs the body's normal production of blood cells, causing extensive scarring in the bone marrow. This leads to severe anemia, weakness, fatigue, and an enlarged spleen. The purpose of this study is to assess …

  • 809 views
  • 15 Jun, 2022
  • 226 locations
Featured trial
Study of Oral Navitoclax Tablet In Combination With Oral Ruxolitinib Tablet When Compared With Oral Ruxolitinib Tablet To Assess Change In Spleen Volume In Adult Participants With Myelofibrosis

www.MyelofibrosisResearch.com Myelofibrosis is a type of bone marrow cancer that usually develops slowly and disrupts body's normal production of blood cells. It causes bone marrow scarring, leading to severe anemia that can cause weakness and fatigue. It can also cause a low number of blood-clotting cells called platelets, which increases …

  • 380 views
  • 16 Jun, 2022
  • 150 locations
Featured trial
Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (POD1UM-303/InterAACT 2).

This study is a Phase 3 global, multicenter, placebo-controlled double-blind randomized study that will enroll participants with inoperable locally recurrent or metastatic SCAC not previously treated with systemic chemotherapy.

  • 10 views
  • 15 Jun, 2022
  • 81 locations
Featured trial
Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (POD1UM-303/InterAACT 2).

This study is a Phase 3 global, multicenter, placebo-controlled double-blind randomized study that will enroll participants with inoperable locally recurrent or metastatic SCAC not previously treated with systemic chemotherapy.

  • 1242 views
  • 15 Jun, 2022
  • 84 locations
Featured trial
A Study to Test the Efficacy, Safety, and Tolerability of Bepranemab (UCB0107) in Patients With Mild Cognitive Impairment or Mild Alzheimer's Disease (AD)

Welcome to TogetherA study for memory loss If you are concerned about changes to your memory, joining the Together clinical study might be a suitable option for you. To qualify for this study, you must:·         Be between 50 and 80 years old·         Have mild memory problems or early Alzheimer’s disease·         Meet some additional study criteria The …

amyloid
mini-mental state examination
cognitive assessment
mild cognitive impairment
alzheimer's disease
  • 39 views
  • 09 Jun, 2022
  • 86 locations
Featured trial
A Study to Evaluate the Safety Tolerability and Pharmacokinetics of BIIB094 in Adults With Parkinson's Disease

The primary objective of this study is to evaluate the safety and tolerability of single and multiple doses of BIIB094 administered via intrathecal (IT) injection to participants with Parkinson's Disease (PD). The secondary objective of this study is to evaluate the pharmacokinetic (PK) profile of BIIB094.The study is open for …

dyskinesia
  • 821 views
  • 23 Jun, 2022
  • 16 locations
Featured trial
Obsessive-Compulsive Disorder

Male and female outpatient subjects between the ages of 18 - 65 years, inclusive, with a primary DSM-V diagnosis of Obsessive Compulsive Disorder who have had an inadequate response to Standard of Care medications. Eligibility Criteria: It is required that all women of child-bearing potential (WOCBP) who are sexually active …

  • 4173 views
  • 07 Nov, 2020
  • 1 location